Depomed Inc (DEPO)

5.94
NASDAQ : Health Care
Prev Close 5.94
Day Low/High 0.00 / 0.00
52 Wk Low/High 5.81 / 27.02
Avg Volume 1.56M
Exchange NASDAQ
Shares Outstanding 62.99M
Market Cap 377.30M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Depomed, Inc. Of Class Action Lawsuit And Upcoming Deadline - DEPO

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Depomed, Inc. Of Class Action Lawsuit And Upcoming Deadline - DEPO

Pomerantz LLP announces that a class action lawsuit has been filed against Depomed, Inc.

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Depomed, Inc. Shareholders And A Lead Plaintiff Deadline Of October 17, 2017

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Depomed, Inc. Shareholders And A Lead Plaintiff Deadline Of October 17, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Depomed, Inc.

DEPO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Depomed, Inc. And A Lead Plaintiff Deadline Of October 17, 2017

DEPO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Depomed, Inc. And A Lead Plaintiff Deadline Of October 17, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Depomed, Inc.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Depomed, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 17, 2017

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Depomed, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 17, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Depomed, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Depomed, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Depomed, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

The Klein Law Firm Announces A Class Action Filed On Behalf Of Depomed, Inc. Shareholders And A Lead Plaintiff Deadline Of October 17, 2017

The Klein Law Firm Announces A Class Action Filed On Behalf Of Depomed, Inc. Shareholders And A Lead Plaintiff Deadline Of October 17, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Depomed, Inc.

DEPO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Depomed, Inc. And A Lead Plaintiff Deadline Of October 17, 2017

DEPO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Depomed, Inc. And A Lead Plaintiff Deadline Of October 17, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Depomed, Inc.

DEPOMED INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Depomed, Inc. To Contact The Firm

DEPOMED INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Depomed, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Depomed, Inc.

DEPO LOSS NOICE: Rosen Law Firm Reminds Depomed, Inc. Investors Of Important Deadline In Class Action - DEPO

DEPO LOSS NOICE: Rosen Law Firm Reminds Depomed, Inc. Investors Of Important Deadline In Class Action - DEPO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Depomed, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Depomed, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 17, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Depomed, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 17, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Depomed, Inc.

The Klein Law Firm Reminds Investors Of Commencement Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Depomed, Inc.

The Klein Law Firm Reminds Investors Of Commencement Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Depomed, Inc.

The Klein Law Firm announces the commencement of an investigation of Depomed, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Depomed, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Depomed, Inc.

The Klein Law Firm announces the commencement of an investigation of Depomed, Inc.

Scott+Scott, Attorneys At Law, LLP Announces Lead Plaintiff Deadline In Federal Securities Case Against Depomed, Inc. (NASDAQ: DEPO)

Scott+Scott, Attorneys At Law, LLP Announces Lead Plaintiff Deadline In Federal Securities Case Against Depomed, Inc. (NASDAQ: DEPO)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, announces that October 17, 2017, is the deadline for interested investors to move to be the lead...

DEPO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Depomed, Inc. (DEPO)

DEPO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Depomed, Inc. (DEPO)

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Depomed, Inc.

DEPO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Depomed, Inc.

DEPO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Depomed, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Depomed, Inc.

First Week of October 20th Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options become available this week, for the October 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DEPO options chain for the new October 20th contracts and identified one put and one call contract of particular interest.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Depomed, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Depomed, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Depomed, Inc.

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

The companies are subject to either state, federal or congressional inquiries into their marketing practices for prescription opioids, which are blamed for helping to fuel rising numbers or addicted individuals.

TheStreet Quant Rating: D (Sell)